CCM
BLFS icon

Channing Capital Management’s BioLife Solutions BLFS Stock Holding History

Channing Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,106
Closed -$444K – 155
2023
Q2 		$444K Buy
+20,106
New +$423K 0.01% 113

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Channing Capital Management's BLFS Position: Q3 2023 in Review

Channing Capital Management sold out of BioLife Solutions (BLFS) in Q3 2023, closing a stake of 20,106 shares — an estimated $444K sold.

Channing Capital Management first reported a position in BLFS in Q2 2023 and held it in 1 quarter. The position peaked at $444K in Q2 2023. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

  • Channing Capital Management reported no remaining BioLife Solutions position as of Q3 2023 after selling out during the quarter.
  • Channing Capital Management sold 20,106 BioLife Solutions shares in Q3 2023, an estimated $444K.
  • Channing Capital Management first reported a position in BioLife Solutions in Q2 2023 and held it in 1 quarter.
  • Channing Capital Management's BioLife Solutions position peaked at $444K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on Channing Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.